CoCensys has hands full

CoCensys has hands full

CoCensys Inc. faces the task of reviving its fortunes with a slender cushion of cash following the recent reorganization of its management and partnerships, including the announcement last week that one of two marketed drugs will be dropped and that its top executive R&D position would be

Read the full 510 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers